HomeNRBO • NASDAQ
add
Neurobo Pharmaceuticals Inc
Previous close
$3.73
Day range
$3.60 - $3.80
Year range
$2.89 - $6.75
Market cap
18.40M USD
Avg Volume
30.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.67M | 155.27% |
Net income | -5.31M | -13.64% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.66M | -155.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 22.44M | -32.76% |
Total assets | 22.78M | -32.07% |
Total liabilities | 6.10M | -48.27% |
Total equity | 16.68M | — |
Shares outstanding | 4.91M | — |
Price to book | 1.10 | — |
Return on assets | -57.58% | — |
Return on capital | -73.30% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.31M | -13.64% |
Cash from operations | -3.39M | -87.77% |
Cash from investing | -9.00K | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -3.40M | -112.60% |
Free cash flow | -1.98M | -118.25% |
About
Founded
2014
Website
Employees
8